Professor, Medicine, University of Alabama School of Medicine
Infectious Disease
Dr. Victoria A. Johnson, MD
|
|
Give Review
Victoria Johnson works in the field of Infectious Disease. She went to medical school at University of Minnesota Medical School. University of Minnesota Medical School has a rank of 40 in research and a 10 in primary care Doctor Victoria A. Johnson, MD has written publications. She has 48 publications published with PubMed. The lastest publication is: 'The use of implantable venous access devices (IVADs) in children with hemophilia.'
Publications
- Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227.
- Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061 in Treatment-Naive HCV- Infected Adults: A Randomized, Double-Blind, Phase 1b Study.
- Factors associated with remaining on initial randomized efavirenz-containing regimens.
- Risk of Vancomycin-induced Nephrotoxicity in the Population With Chronic Kidney Disease.
- Structural and Photophysical Properties of Visible- and Near-IR-Emitting Tris Lanthanide(III) Complexes Formed with the Enantiomers of N,N'-Bis(1-phenylethyl)-2,6-pyri...
- 2011 update of the drug resistance mutations in HIV-1.
- Macrocycles that inhibit the binding between heat shock protein 90 and TPR-containing proteins.
- Update of the drug resistance mutations in HIV-1: December 2010.
- Cost ramifications of increased reporting of detectable plasma HIV-1 RNA levels by the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 version 1.0 viral load test.
- Evaluation of di-sansalvamide A derivatives: synthesis, structure-activity relationship, and mechanism of action.
- Update of the drug resistance mutations in HIV-1: December 2009.
- Novel methodology for antiretroviral quantitation in the female genital tract.
- Mass fatality planning for pandemic influenza: a planning model from a seven-county region in Kentucky.
- Update of the Drug Resistance Mutations in HIV-1.
- Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
- Update of the drug resistance mutations in HIV-1: Spring 2008.
- Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected sub...
- Update of the drug resistance mutations in HIV-1: 2007.
- Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.
- Update of the drug resistance mutations in HIV-1: Fall 2006.
- Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency.
- Update of the drug resistance mutations in HIV-1: Fall 2005.
- Update of the Drug Resistance Mutations in HIV-1: 2005.
- Persistent antiretroviral activity of nucleoside analogues after prolonged zidovudine and lamivudine therapy as demonstrated by rapid loss of activity after discontinu...
- Update of the drug resistance mutations in HIV-1: 2004.
- Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.
- Drug resistance mutations in HIV-1.
- Accuracy of the TRUGENE HIV-1 genotyping kit.
- Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500...
- Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the...
- Update of the drug resistance mutations in HIV-1: March 2013.
- Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.
- Macrocyclic inhibitors of hsp90.
- Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.
- A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.
- Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.
- Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel.
- Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370.
- Rate of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimens.
- Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives.
- Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
- Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline.
- A comprehensive study of Sansalvamide A derivatives: The structure-activity relationships of 78 derivatives in two pancreatic cancer cell lines.
- Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.
- Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AID...
- Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.
- The use of implantable venous access devices (IVADs) in children with hemophilia.
Schools
University Of Minnesota Medical School
Dartmouth Hitchcock Med Center
University Colo Health Scis Center
Massachusetts General Hospital
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Massachusetts General Hospital -
University of Colorado -
Dartmouth-Hitchcock Medical Center -
University of Minnesota Medical School
Hospital
-
University of Alabama Hospital -
Birmingham Veterans Affairs Medical Center
Drug Facts
| NPI NUMBER | 1184651630 | |
| NPPES Provider LastName | JOHNSON | |
| NPPES Provider FirstName | VICTORIA | |
| NPPES Provider ZIPCode | 35233 | |
| NPPES Provider State | AL | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 489.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 37.0 | |
| Percent Opioid Claims | 7.57 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1184651630 |
| Last Name Of The Provider | JOHNSON |
| First Name Of The Provider | VICTORIA |
| View All |
Similar Doctors
|
Dr. Ricardo M. La Hoz, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul A. Goepfert, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Michael S. Saag, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. William E. Dismukes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. German F. Henostroza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane R. Schwebke, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. William I. Lapidus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashraf E. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Cafardi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meryl A. Twarog, MD |
|
|
Dr. Scott T. Rottinghaus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina A. Muzny, MD
This Doctor is OpenDoctor Recommended.
|